Literature DB >> 12672061

Combinatorial immunoglobulin light chain variability creates sufficient B cell diversity to mount protective antibody responses against pathogen infections.

Beatrice M Senn1, Constantino López-Macías, Ulrich Kalinke, Alain Lamarre, Armando Isibasi, Rolf M Zinkernagel, Hans Hengartner.   

Abstract

To analyze how combinatorial light (L) chain diversity influences the B cell repertoire, we studied mice with a homozygous immunoglobulin-heavy-chain null mutation (mu MT), in which the B cell developmental block was overridden by the expression of a transgenic immunoglobulin mu heavy (H) chain derived from a vesicular stomatitis virus Indiana serotype (VSV-IND)-neutralizing Ab (T11 mu MT mice). The randomly integrated transgene could not undergo secondary rearrangements and was expressed in combination with endogenous kappa or lambda chains. T11 mu MT mice had a skewed B cell repertoire as evidenced by 30-60% VSV-IND-specific peripheral B cells and spontaneous VSV-IND-neutralizing serum titers. Upon immunization, T11 mu MT mice mounted specific IgM antibody responses against VSV-IND but, interestingly, they also responded against VSV New Jersey serotype (VSV-NJ), lymphocytic choriomeningitis virus, poliovirus and Salmonella typhi porins. Variable-region sequence analysis revealed that VSV-NJ-specific antibodies expressed numerous L chains in combination with the transgenic H chain, which was devoid of hypermutations. Thus, in T11 mu MT mice combinatorial L chain variability alone is able to build up a sufficiently complex B cell repertoire to mount protective immunoglobulin responses against a variety of pathogens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12672061     DOI: 10.1002/eji.200323340

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

1.  A Rational Strategy for Reducing On-Target Off-Tumor Effects of CD38-Chimeric Antigen Receptors by Affinity Optimization.

Authors:  Esther Drent; Maria Themeli; Renée Poels; Regina de Jong-Korlaar; Huipin Yuan; Joost de Bruijn; Anton C M Martens; Sonja Zweegman; Niels W C J van de Donk; Richard W J Groen; Henk M Lokhorst; Tuna Mutis
Journal:  Mol Ther       Date:  2017-05-13       Impact factor: 11.454

2.  A major deletion in the Vκ-Jκ intervening region results in hyperelevated transcription of proximal Vκ genes and a severely restricted repertoire.

Authors:  Yougui Xiang; Sung-Kyun Park; William T Garrard
Journal:  J Immunol       Date:  2014-09-03       Impact factor: 5.422

3.  Salmonella porins induce a sustained, lifelong specific bactericidal antibody memory response.

Authors:  Ismael Secundino; Constantino López-Macías; Luisa Cervantes-Barragán; Cristina Gil-Cruz; Nora Ríos-Sarabia; Rodolfo Pastelin-Palacios; Miguel Angel Villasis-Keever; Ingeborg Becker; José Luis Puente; Edmundo Calva; Armando Isibasi
Journal:  Immunology       Date:  2006-01       Impact factor: 7.397

4.  B Cells Carrying Antigen Receptors Against Microbes as Tools for Vaccine Discovery and Design.

Authors:  Deepika Bhullar; David Nemazee
Journal:  Curr Top Microbiol Immunol       Date:  2019-03-28       Impact factor: 4.291

5.  A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV Infection.

Authors:  Kathrin Endt; Yvonne Wollmann; Jana Haug; Constanze Bernig; Markus Feigl; Alexander Heiseke; Markus Kalla; Hubertus Hochrein; Mark Suter; Paul Chaplin; Ariane Volkmann
Journal:  Front Immunol       Date:  2022-06-14       Impact factor: 8.786

6.  Antibodies raised against chlamydial lipopolysaccharide antigens reveal convergence in germline gene usage and differential epitope recognition.

Authors:  Cory L Brooks; Sven Müller-Loennies; Svetlana N Borisova; Lore Brade; Paul Kosma; Tomoko Hirama; C Roger Mackenzie; Helmut Brade; Stephen V Evans
Journal:  Biochemistry       Date:  2010-01-26       Impact factor: 3.162

7.  Antiviral immune responses in gene-targeted mice expressing the immunoglobulin heavy chain of virus-neutralizing antibodies.

Authors:  Lars Hangartner; Beatrice M Senn; Birgit Ledermann; Ulrich Kalinke; Peter Seiler; Etienne Bucher; Raphaël M Zellweger; Katja Fink; Bernhard Odermatt; Kurt Bürki; Rolf M Zinkernagel; Hans Hengartner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205

8.  Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles.

Authors:  Robert W Maitta; Kausik Datta; Qing Chang; Robin X Luo; Bradley Witover; Krishanthi Subramaniam; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

9.  Identification of recombinant antibodies against multiple distinct toll-like receptors by homolog mining a single immune scFv phage library.

Authors:  Yu-Hsun Chen; Barbara D Lipes; Daniel J Kenan; Herman F Staats; Michael D Gunn
Journal:  J Immunol Methods       Date:  2008-11-17       Impact factor: 2.303

10.  Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway.

Authors:  Jianhua Sui; Daniel R Aird; Azaibi Tamin; Akikazu Murakami; Meiying Yan; Anuradha Yammanuru; Huaiqi Jing; Biao Kan; Xin Liu; Quan Zhu; Qing-An Yuan; Gregory P Adams; William J Bellini; Jianguo Xu; Larry J Anderson; Wayne A Marasco
Journal:  PLoS Pathog       Date:  2008-11-07       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.